A dynamic leader in Life Sciences, notably in government affairs, market access, and pricing, with over a decade of experience driving strategic health policy and commercial outcomes across 32 European markets. She brings deep life sciences expertise and strategic leadership to advance NextGen indication strategy and support the company’s global expansion. As a member of the Advisory Board and former President of AseBio, she champions the industry successfully leading multistakeholder initiatives.

Ana is a recognized advocate for gender equity in STEM, spearheading the ClosinGap initiative that revealed an outstanding € 256 billion annual opportunity from closing Spain’s gender gap. She is also a trusted voice on R&D investment, innovation, and public–private collaboration, regularly guiding European and national dialogues,

Her insights into the European market are integral to refining chAIron’s roadmap and de‑risking drug development for the company's partners.